The Montreal General Hospital
Welcome,         Profile    Billing    Logout  
 6 Trials 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Garg, Amit
NCT00319579: Pilot Prospective Study: Long-term Health of Living Kidney Donors

Completed
N/A
330
Canada, US, RoW
Amit Garg, Canadian Institutes of Health Research (CIHR)
Living Kidney Donors
08/09
08/09
DIALEX, NCT06660277: DIALysis with EXpanded Solute Removal

Not yet recruiting
N/A
4800
Canada
Super High-Flux Dialyzer, expanded hemodialysis, Nipro ELISIO HX, High-Flux Dialyzer, conventional hemodialysis
Western University, Canada, Schulich School of Medicine and Dentistry, ICES, Population Health Research Institute, Nipro Canada Corporation, London Health Sciences Centre
Chronic Kidney Disease Requiring Hemodialysis, End-Stage Kidney Disease (ESKD)
01/30
01/30
NCT06270134: Dial-Bicarb Trial: Effects of a Lower vs. Higher Concentration of Dialysate Bicarbonate

Not yet recruiting
N/A
5000
NA
Bicarbonate
McMaster University, Canadian Institutes of Health Research (CIHR)
Hemolysis, Renal Failure
01/29
01/29
NCT04079582: Outcomes of a Higher vs. Lower Hemodialysate Magnesium Concentration (Dial-Mag Canada)

Active, not recruiting
N/A
25000
Canada
Dialysate magnesium formulation of 1.5 mEq/L (0.75 mmol/L)., Dialysate magnesium formulation of ≤1.0 mEq/L (≤0.5 mmol/L).
Lawson Health Research Institute, ICES, Canadian Institutes of Health Research (CIHR)
Kidney Diseases, End-Stage Kidney Disease, Hemodialysis
03/26
03/26
Feldman, Liane
NCT04643314: Effect of Video-based Guided Self-reflection on Intraoperative Skills

Recruiting
N/A
34
Canada
Guided video-based self-evaluation
McGill University Health Centre/Research Institute of the McGill University Health Centre
Laparoscopy
07/21
07/21
NCT03461497: Development of a Patient-Reported Outcome Measure to Assess Recovery After Abdominal Surgery

Active, not recruiting
N/A
530
Europe, Canada, Japan, RoW
McGill University Health Centre/Research Institute of the McGill University Health Centre, Hospital São Paulo, Brazil, Hokkaido University Hospital, San Raffaele University Hospital, Italy
Abdominal Surgery
12/25
12/25
Afif, Waqqas
ABX464-105, NCT05507203: ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

Recruiting
3
612
Europe, Canada, US, RoW
ABX464, Obefazimod, Placebo
Abivax S.A.
Ulcerative Colitis
03/25
04/25
ABTECT, NCT05535946: - Maintenance

Recruiting
3
1050
Europe, Canada, Japan, US, RoW
ABX464, Obefazimod, Placebo
Abivax S.A.
Ulcerative Colitis
01/26
01/30
LUCENT-3, NCT03519945 / 2017-004092-31: A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

Hourglass Jan 2022 - Mar 2022 : Data from LUCENT 3 trial for moderate-to-severe ulcerative colitis
Recruiting
3
1063
Europe, Canada, Japan, US, RoW
Mirikizumab, LY3074828
Eli Lilly and Company
Ulcerative Colitis
07/26
12/27
RESOLVE, NCT05608681: A Trial to Evaluate EP-104IAR in Adults With Eosinophilic Esophagitis (EoE).

Recruiting
1/2
57
Europe, Canada, RoW
EP-104IAR
Eupraxia Pharmaceuticals Inc.
Eosinophilic Esophagitis
12/25
12/25
NCT03261102: TDM Guided Early Optimization of ADAL in Crohn's Disease

Recruiting
N/A
200
Canada
Adalimumab, Humira
waqqas.afif, AbbVie
Crohn Disease, Drug Monitoring, Inflammatory Bowel Diseases
12/23
06/24

Download Options